Quantum Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Quantum BioPharma
QNTM Stock   4.87  0.04  0.81%   
Quantum BioPharma's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Quantum BioPharma's valuation are provided below:
Market Capitalization
19.8 M
Enterprise Value Revenue
98.5599
Earnings Share
(9.55)
There are over one hundred nineteen available trending fundamental ratios for Quantum BioPharma, which can be analyzed over time and compared to other ratios. Self-guided Investors are advised to check out Quantum BioPharma's recent fundamentals against the trend between 2010 and 2026 to make sure the company can sustain itself down the road. As of the 29th of January 2026, Market Cap is likely to drop to about 4.6 M. In addition to that, Enterprise Value is likely to grow to about (1.1 M)
Check Quantum BioPharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Quantum BioPharma's main balance sheet or income statement drivers, such as Selling General Administrative of 13.3 M, Other Operating Expenses of 19.3 M or Total Operating Expenses of 19.1 M, as well as many indicators such as Price To Sales Ratio of 4.4 K, Dividend Yield of 0.0 or PTB Ratio of 0.34. Quantum financial statements analysis is a perfect complement when working with Quantum BioPharma Valuation or Volatility modules.
  
Build AI portfolio with Quantum Stock
Check out the analysis of Quantum BioPharma Correlation against competitors.
To learn how to invest in Quantum Stock, please use our How to Invest in Quantum BioPharma guide.

Quantum BioPharma Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets29.8 M19.7 M18.8 M
Slightly volatile
Short and Long Term Debt Total497.5 K742.4 K614.6 K
Slightly volatile
Other Current Liabilities2.4 M1.8 M1.5 M
Slightly volatile
Total Current Liabilities4.7 M7.7 M3.3 M
Slightly volatile
Accounts Payable2.2 M3.7 M1.5 M
Slightly volatile
Net Receivables4.6 M4.4 M1.4 M
Slightly volatile
Common Stock Shares Outstanding1.4 M1.3 M397.2 K
Slightly volatile
Liabilities And Stockholders Equity29.8 M19.7 M18.8 M
Slightly volatile
Other Stockholder Equity19.8 M38 M14 M
Slightly volatile
Total Liabilities4.7 M7.7 M3.3 M
Slightly volatile
Total Current Assets15.8 M13.9 M10.2 M
Slightly volatile
Short Term Debt627.8 K948.7 K593.9 K
Slightly volatile
Common Stock90.6 M173 M64.2 M
Slightly volatile
Cash12.7 M6.9 M7.3 M
Slightly volatile
Cash And Short Term Investments12.9 M8.3 M7.5 M
Slightly volatile
Non Current Assets Total4.3 M4.6 M10.7 M
Pretty Stable
Other Current Assets1 M1.1 M1.5 M
Pretty Stable
Intangible Assets4.2 M4.4 M13.5 M
Slightly volatile
Capital Lease Obligations46 K48.4 K120.2 K
Slightly volatile
Net Invested Capital10.5 M11 M31.5 M
Slightly volatile
Long Term Investments1.9 K2 K1.2 M
Slightly volatile
Short and Long Term Debt452.6 K886.8 K426.1 K
Slightly volatile
Capital Stock151.2 M173 M120.2 M
Slightly volatile
Net Working Capital4.6 M4.8 M17.8 M
Slightly volatile
Non Currrent Assets Other775.8 K816.6 K5.9 M
Slightly volatile
Current Deferred Revenue800 K900 K982.4 K
Slightly volatile

Quantum BioPharma Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative13.3 M10.7 M8.5 M
Slightly volatile
Other Operating Expenses19.3 M18.6 M12.6 M
Slightly volatile
Total Operating Expenses19.1 M18.6 M12.4 M
Slightly volatile
Depreciation And Amortization535.9 K564.2 K1.2 M
Slightly volatile
Selling And Marketing Expenses1.6 M1.9 M2 M
Slightly volatile
Interest Expense74.3 K42.8 K121.9 K
Slightly volatile
Cost Of Revenue419.4 K441.5 K1.4 M
Slightly volatile
Interest Income381 K658.8 K165.2 K
Slightly volatile
Research Development5 M5.5 M7 M
Slightly volatile
Reconciled Depreciation419.4 K441.5 K3.3 M
Slightly volatile

Quantum BioPharma Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow3 M3.2 M6.1 M
Slightly volatile
End Period Cash Flow12.7 M6.9 M7.3 M
Slightly volatile
Stock Based Compensation130.1 K137 K3.4 M
Very volatile
Depreciation535.9 K564.2 K1.2 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio4.4 K5 K5.4 K
Slightly volatile
Days Sales Outstanding3.3 K3.7 K4.1 K
Slightly volatile
Average Payables2.2 M2.4 M2.7 M
Slightly volatile
Stock Based Compensation To Revenue92.22104113
Slightly volatile
Capex To Depreciation0.08770.092311.7349
Slightly volatile
EV To Sales4.3 K4.8 K5.2 K
Slightly volatile
Inventory Turnover2.32.592.8244
Slightly volatile
Days Of Inventory On Hand102114125
Slightly volatile
Payables Turnover0.490.550.5966
Slightly volatile
Sales General And Administrative To Revenue109123134
Slightly volatile
Average Inventory283.8 K319.2 K348.4 K
Slightly volatile
Capex To Revenue236266290
Slightly volatile
Cash Per Share6.927.2830.3609
Pretty Stable
Days Payables Outstanding481541591
Slightly volatile
Income Quality0.450.410.3818
Slightly volatile
Intangibles To Total Assets0.340.330.3557
Slightly volatile
Current Ratio2.821.622.5911
Slightly volatile
Receivables Turnover0.07050.07930.0865
Slightly volatile
Capex Per Share0.670.730.7312
Slightly volatile
Average Receivables3.7 M3.5 M1.1 M
Slightly volatile
Revenue Per Share0.160.180.2002
Slightly volatile
Interest Debt Per Share0.840.885.3168
Very volatile
Debt To Assets0.05260.05542.4783
Slightly volatile
Operating Cycle1391462 K
Slightly volatile
Days Of Payables Outstanding481541591
Slightly volatile
Ebt Per Ebit1.121.061.0476
Very volatile
Quick Ratio2.811.612.5828
Slightly volatile
Net Income Per E B T1.121.11.0986
Slightly volatile
Cash Ratio0.981.032.0031
Pretty Stable
Days Of Inventory Outstanding102114125
Slightly volatile
Days Of Sales Outstanding3.3 K3.7 K4.1 K
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.111.1625.0676
Slightly volatile
Fixed Asset Turnover0.00250.00280.0031
Slightly volatile
Debt Ratio0.05260.05542.4783
Slightly volatile
Price Sales Ratio4.4 K5 K5.4 K
Slightly volatile
Asset Turnover0.00150.00170.0019
Slightly volatile

Quantum BioPharma Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap4.6 M4.8 M78.5 M
Slightly volatile

Quantum Fundamental Market Drivers

About Quantum BioPharma Financial Statements

Quantum BioPharma investors utilize fundamental indicators, such as revenue or net income, to predict how Quantum Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue900 K800 K
Cost Of Revenue441.5 K419.4 K
Stock Based Compensation To Revenue 103.75  92.22 
Sales General And Administrative To Revenue 123.17  109.49 
Capex To Revenue 265.52  236.02 
Revenue Per Share 0.18  0.16 
Ebit Per Revenue(122.27)(128.39)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Quantum BioPharma is a strong investment it is important to analyze Quantum BioPharma's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Quantum BioPharma's future performance. For an informed investment choice regarding Quantum Stock, refer to the following important reports:
How To Invest In Quantum
Details
Is Quantum Stock a good investment?
Details
What is Quantum BioPharma's Net Worth?
Details
Largest Biotechnology Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of Quantum BioPharma Correlation against competitors.
To learn how to invest in Quantum Stock, please use our How to Invest in Quantum BioPharma guide.
You can also try the Stocks Directory module to find actively traded stocks across global markets.
Will Biotechnology sector continue expanding? Could Quantum diversify its offerings? Factors like these will boost the valuation of Quantum BioPharma. Anticipated expansion of Quantum directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Quantum BioPharma data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(9.55)
Return On Assets
(0.72)
Return On Equity
(2.51)
The market value of Quantum BioPharma is measured differently than its book value, which is the value of Quantum that is recorded on the company's balance sheet. Investors also form their own opinion of Quantum BioPharma's value that differs from its market value or its book value, called intrinsic value, which is Quantum BioPharma's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Quantum BioPharma's market value can be influenced by many factors that don't directly affect Quantum BioPharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
It's important to distinguish between Quantum BioPharma's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Quantum BioPharma should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Quantum BioPharma's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY